On CNBC's "Halftime Report Final Trades," Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC named Pfizer Inc. (NYSE:PFE) as her final trade.
On Wednesday, the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted for expanded usage recommendation for Merck & Co Inc's (NYSE:MRK) and Pfizer's pneumococcal conjugate vaccines. The CDC panel has recommended lowering the pneumococcal vaccination age from 65 to 50 years old.
Liz Young Thomas of SoFi picked SPDR S&P Aerospace & Defense ETF (NYSE:XAR).
Don't forget to check out our premarket coverage here
Joshua Brown of Ritholtz Wealth Management named Live Nation Entertainment, Inc. (NYSE:LYV).
The company will release its third quarter financial results on Tuesday, Nov. 12. Analysts expect the company to report quarterly earnings at $1.61 per share, down from $1.78 per share in the year-ago period. The company projects to report revenue of $7.8 billion, compared to $6.99 billion a year earlier.
On Thursday, JP Morgan analyst David Karnovsky maintained Live Nation Entertainment with an Overweight and raised the price target from $118 to $137.
Price Action:
- Pfizer shares fell 0.8% to close at $28.64 during Thursday's session.
- SPDR S&P Aerospace & Defense ETF slipped 0.9% during Thursday's session.
- Live Nation Entertainment shares gained 1.5% to close at $116.45 on Thursday.
- Jim Cramer Says 'Hold On' To Palantir, 'Let Them Walk It Up'; Warns That Travere Therapeutics Is Losing A 'Ton Of Money'
Image: Shutterstock